Found 2897 matching trials
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer PHASE2 Researchers conducting this study hope to learn about the safety and effect...
Show More Location
University of Chicago Comprehensive Cancer Center
Learn More & Join Trial
IL-1ra Dose-range Study for Moderate-to-severe TBI Patients PHASE2 Traumatic brain injury (TBI) is a common condition with high degree of morb...
Show More Location
Cambridge University Hospital NHS Trust
Learn More & Join Trial
Study of Olaparib (± Degarelix) Given to Men With Intermediate/High Risk Prostate Cancer Before Prostatectomy PHASE1 Despite recent advances in the treatment of Castrate-Resistant Prostate Can...
Show More Location
Addenbrooke's Hospital, Cambridge University Hospitals Foundation Trust,
Learn More & Join Trial
Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease PHASE2 This study evaluates the tolerability, safety and activity of SRX246 in the...
Show More Location
University of Alabama
Learn More & Join Trial
Clinical Trial of Anovulatory Infertility EARLY_PHASE1 This project aims to study the expression of clock genes and related protei...
Show More Status
Enrolling By Invitation
Location
Affiliated Hospital of Nanjing University of Chinese Medicine
Learn More & Join Trial
NAC Effect on Infertile Women With Endometrioma PHASE3 Oxidative stress has been investigated as a key factor in the pathogenesis ...
Show More Learn More & Join Trial
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC PHASE3 The purpose of this study is to determine if the addition of apalutamide to...
Show More Status
Active Not Recruiting
Location
Multiple Locations
Learn More & Join Trial
Progesterone Primed Ovarian Stimulation Protocol Versus Antagonist Protocol for PCO Patient NA this study is designed to compare the Progesterone primed ovarian stimulati...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR Levels N/A This study aims to investigate the pathophysiology of recurrent pericarditi...
Show More Location
Saarland University
Learn More & Join Trial
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007) PHASE3 The primary objective of the study is to compare sacituzumab tirumotecan co...
Show More Location
Mayo Clinic in Arizona - Phoenix ( Site 0147)
Learn More & Join Trial